First topical therapy for chronic hand eczema wins the approval of the FDA

(Medage today) – The first therapy specifically indicated for the eczema of the Chronic Hand (CHE) managed to gather at the FDA. The agency approved the 2% Delgocitinib cream (ANZUPGO) for adults with moderate to severe che, according to a statement from Leo …